FIELD: medicine, therapy, endocrinology. SUBSTANCE: invention relates to treatment of patients with hypercalcemia of different genesis. For this purpose invention proposes to administrate substances of benzothiophene group, in part, raloxifene in the dose 200-600 mg/day. Method exhibits the significant clinical effect preventing relapses of disease. EFFECT: enhanced effectiveness of treatment. 4 cl
Authors
Dates
2001-12-10—Published
1996-01-29—Filed